Who Paid My Doc
James Badgett
Pediatric Hematology-Oncology Baltimore, MD Medical Doctor
NPI 1336283654 CMS profile 771715
600 N Wolfe St, Cmsc 800, Baltimore, MD 21287
General payments
$1,233
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$55,334
Through program year 2025, James Badgett of Baltimore, MD is reported in the CMS Open Payments database as having received $1,233 across 1 general payment and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $55,334 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 57th percentile of Pediatric Hematology-Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,233 | 1 |
Beside peers
- James Badgett
- Pediatric Hematology-Oncology median
- Middle half of Pediatric Hematology-Oncology
- National median
In program year 2025, general payments to James Badgett were reported at $1,233. Among 1,352 Pediatric Hematology-Oncology profiles paid that year, the median was $204 and the middle half received between $80 and $2,819.
Show as a table
| Year | James Badgett | Pediatric Hematology-Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $184 | $69–$2,094 | $163 |
| 2020 | $0 | $220 | $37–$3,941 | $114 |
| 2021 | $0 | $366 | $63–$4,909 | $132 |
| 2022 | $0 | $181 | $66–$2,775 | $149 |
| 2023 | $0 | $175 | $62–$2,600 | $160 |
| 2024 | $0 | $227 | $66–$2,992 | $164 |
| 2025 | $1,233 | $204 | $80–$2,819 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
11
Drug cost
$20,308
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Fulphila Pegfilgrastim-Jmdb | Brand | 11 | $20,308 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 8,746 Part D prescribers listed as Hematology-Oncology; they describe a distribution and say nothing about conduct.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Hematology-Oncology in Maryland
Kenneth Cooke
Pediatric Hematology-Oncology · Baltimore, MD
Lydia Pecker
Pediatric Hematology-Oncology · Baltimore, MD
Vemulkonda Rao
Pediatric Hematology-Oncology · Bethesda, MD
Stacy Cooper
Pediatric Hematology-Oncology · Baltimore, MD
Heather Symons
Pediatric Hematology-Oncology · Baltimore, MD
Gregory Kato
Pediatric Hematology-Oncology · Bethesda, MD
Related records
Pediatric Hematology-Oncology in Maryland
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Hematology-Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Maryland
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.